Literature DB >> 21632649

Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study.

Konasale M Prasad1, Shaun M Eack, Dhruman Goradia, Krishna M Pancholi, Matcheri S Keshavan, Robert H Yolken, Vishwajit L Nimgaonkar.   

Abstract

OBJECTIVE: Longitudinal changes in gray matter volume and cognitive performance were evaluated among individuals exposed to neurotropic herpes simplex virus subtype 1 (HSV1). There is a replicable association of HSV1 exposure with smaller prefrontal volumes and cognitive impairments in schizophrenia.
METHOD: The authors concurrently examined the whole-brain longitudinal trajectory over 1 year of gray matter volumes and executive functioning measured with the Wisconsin Card Sorting Test among 26 first-episode antipsychotic-naive subjects with schizophrenia and 38 healthy subjects. Age, gender, socioeconomic status, and exposure to cytomegalovirus (another virus of the herpes family that was previously associated with cognitive impairments) were the covariates.
RESULTS: Significant gray matter loss in the posterior cingulate gyrus was noted among the HSV1-seropositive schizophrenia subjects over 1 year but not among other groups. Prefrontal gray matter volumes did not show longitudinal changes. Binomial mixed-effects models indicated that improvement over 1 year in Wisconsin Card Sorting Test categories completed and perseverative errors occurred in significantly fewer HSV1-seropositive schizophrenia subjects than in the HSV1-seronegative schizophrenia subjects or the healthy subjects regardless of serological status. Three-way interactions of diagnosis, HSV1 status, and time were significant for both categories completed and perseverative errors. An increase in perseverative errors over 1 year, but not the change in the number of categories completed, correlated with longitudinal volume loss of the posterior cingulate gyrus.
CONCLUSIONS: These observations suggest that HSV1 exposure may be associated with longitudinal gray matter loss in the posterior cingulate gyrus and decline in executive functioning among subjects with schizophrenia.

Entities:  

Mesh:

Year:  2011        PMID: 21632649      PMCID: PMC4209378          DOI: 10.1176/appi.ajp.2011.10101423

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  38 in total

1.  Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.

Authors:  N Tzourio-Mazoyer; B Landeau; D Papathanassiou; F Crivello; O Etard; N Delcroix; B Mazoyer; M Joliot
Journal:  Neuroimage       Date:  2002-01       Impact factor: 6.556

2.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets.

Authors:  Joseph A Maldjian; Paul J Laurienti; Robert A Kraft; Jonathan H Burdette
Journal:  Neuroimage       Date:  2003-07       Impact factor: 6.556

Review 3.  Cognitive impairment in schizophrenia is the core of the disorder.

Authors:  B Elvevåg; T E Goldberg
Journal:  Crit Rev Neurobiol       Date:  2000

4.  Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1.

Authors:  M Aubert; J O'Toole; J A Blaho
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

6.  Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect.

Authors:  T W Weickert; T E Goldberg; J M Gold; L B Bigelow; M F Egan; D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2000-09

7.  Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8.

Authors:  Lauren M Ellman; Raymond F Deicken; Sophia Vinogradov; William S Kremen; John H Poole; David M Kern; Wei Yann Tsai; Catherine A Schaefer; Alan S Brown
Journal:  Schizophr Res       Date:  2010-06-09       Impact factor: 4.939

8.  Frontal lobe damage and tests of executive processing: a meta-analysis of the category test, stroop test, and trail-making test.

Authors:  George J Demakis
Journal:  J Clin Exp Neuropsychol       Date:  2004-05       Impact factor: 2.475

9.  Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia.

Authors:  Faith B Dickerson; John J Boronow; Cassie Stallings; Andrea E Origoni; Inna Ruslanova; Robert H Yolken
Journal:  Arch Gen Psychiatry       Date:  2003-05

Review 10.  Computer-assisted imaging to assess brain structure in healthy and diseased brains.

Authors:  John Ashburner; John G Csernansky; Christos Davatzikos; Nick C Fox; Giovanni B Frisoni; Paul M Thompson
Journal:  Lancet Neurol       Date:  2003-02       Impact factor: 44.182

View more
  27 in total

Review 1.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

Review 2.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

3.  Association of cognitive function and liability to addiction with childhood herpesvirus infections: A prospective cohort study.

Authors:  Michael M Vanyukov; Vishwajit L Nimgaonkar; Levent Kirisci; Galina P Kirillova; Maureen D Reynolds; Konasale Prasad; Ralph E Tarter; Robert H Yolken
Journal:  Dev Psychopathol       Date:  2017-04-19

4.  Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial.

Authors:  Konasale M Prasad; Shaun M Eack; Matcheri S Keshavan; Robert H Yolken; Satish Iyengar; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2012-03-23       Impact factor: 9.306

Review 5.  Genetics of schizophrenia from a clinicial perspective.

Authors:  Prachi Kukshal; B K Thelma; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Int Rev Psychiatry       Date:  2012-10

Review 6.  Viral infection, inflammation and schizophrenia.

Authors:  Rachel E Kneeland; S Hossein Fatemi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-10       Impact factor: 5.067

7.  Emotion discrimination in humans: Its association with HSV-1 infection and its improvement with antiviral treatment.

Authors:  Triptish Bhatia; Joel Wood; Satish Iyengar; Sreelatha S Narayanan; Ram Pratap Beniwal; Konasale M Prasad; Kehui Chen; Robert H Yolken; Faith Dickerson; Ruben C Gur; Raquel E Gur; Smita N Deshpande; Vishwajit L Nimgaonkar
Journal:  Schizophr Res       Date:  2017-08-19       Impact factor: 4.939

8.  Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey.

Authors:  Kara D Tarter; Amanda M Simanek; Jennifer B Dowd; Allison E Aiello
Journal:  J Infect Dis       Date:  2013-11-18       Impact factor: 5.226

9.  Inflammatory molecular signature associated with infectious agents in psychosis.

Authors:  Lindsay N Hayes; Emily G Severance; Jeffrey T Leek; Kristin L Gressitt; Cathrin Rohleder; Jennifer M Coughlin; F Markus Leweke; Robert H Yolken; Akira Sawa
Journal:  Schizophr Bull       Date:  2014-04-17       Impact factor: 9.306

10.  Exposure to herpes simplex virus, type 1 and reduced cognitive function.

Authors:  Pramod Thomas; Triptish Bhatia; Deepak Gauba; Joel Wood; Colleen Long; Konasale Prasad; Faith B Dickerson; Raquel E Gur; Ruben C Gur; Robert H Yolken; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  J Psychiatr Res       Date:  2013-08-03       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.